A 2018 Graphene Nanopores Study at University of Exeter Caused Myocarditis in Rats
This is a quick followup to the article I wrote last night, where I challenged McCullough and Makis to provide any evidence they had that spike proteins have caused Myocarditis prior to the rollout of the “COVID” vaccines. I also proposed a quick test to determine if Graphene or Spike Proteins were more likely to cause Myocarditis.
Challenge for William Makis and Peter McCullough on Spike Proteins and Myocarditis
At present, there are only a handful of prominent doctors, scientists, and medical professionals who have broken ranks with their peers and said that there was no viral pandemic described as “COVID,” meaning that all “COVID” deaths were the result of vaccines or deadly measures in hospitals. Michael Yeadon, Sasha Latypova, Paul Alexander and Robert You…
Right after I published it, I decided to do a really deep dive into Graphene and Myocarditis and typed “graphene myocarditis” into a search engine. Up popped a paper published in Applied Materials Today in 2018 titled “Investigation into the toxic effects of graphene nanopores on lung cancer cells and biological tissues.” It turns out that researchers had already injected rats with Graphene.
The lead author of the paper, Tanveer A. Tabish, is listed as a member of the Centre for Graphene Science, University of Exeter, Exeter EX4 4QL, United Kingdom. Here’s a short video on some of their graphene research in electronics.
Myocarditis is an electrical malfunction of the heart that normally occurs after inflammation of the heart, but in the presence of graphene around the heart, I doubt that inflammation is required to generate an electrical malfunction due to the extremely high electrical conducting efficiency of Graphene. The heart can also be started and stopped using electricity. Tests for heart problems use an Electrocardiogram. Pacemakers use low-energy electrical pulses to control the rate and rhythm of heartbeat.
In yesterday’s article I suggested injecting hamsters with Graphene to observe the effects then conduct autopsies. It turns out that Exeter had in fact observed Myocarditis using graphene nanopores in rats.
Science Direct has a page that describes nanopores. There are several definitions from various scientists.
Nanopores are tiny nanodevice with pores with nanoscale diameter. The ssDNA is made to pass through the nanopores.
A nanopore is a very small pore in a thin membrane, typically just big enough to pass through a single strand of DNA. Thus, shape and electrical properties of each base on a DNA strand may be assessed and consequently provide an opportunity for reading the genetic codes.
It’s clear that graphene is heavily researched due to its excellent properties in conducting electricity, which could be developed for tiny nanodevices which run on electricity. Torbin et al wrote:
As an inexpensive monolayer archetypal member of the carbon family, graphene has triggered a new ‘gold rush’ in nanotechnology for achieving unique properties that were not available in many traditional materials. Owing to these unique features, graphene-related materials are finding new uses in nanomedicine and synthetic biology in addition to their diverse applications in electronics, optoelectronics, photonics and environmental clean-up. The increased production of graphene nanostructures and increased likelihood of exposures to these substances in environmental and occupational settings has raised concerns about adverse health outcomes.
The authors said that graphene was awesome because it could be made small enough to cross the blood brain barrier. That’s what everyone needs- graphene nanopores in your brains. And tumors. This isn’t Medicine. It’s Circuitry.
One important advantage of graphene-based materials is their ability to effectively cross biological barriers such as the blood brain barrier, highlighting their potential as a drug delivery vehicle for anticancer therapeutic agents. In particular, the combined enhanced permeability and retention effect would facilitate their accumulation in tumours, releasing therapeutic levels of drugs into the target cells with reduced side effects
The researchers injected Graphene Nanopores into rats to assess the safety profile. They didn’t describe the exact structure or intended “medical” function of these particular GNPS.
In vivo toxicity of GNPs (Graphene Nanopores) was assessed in rats following 27-day repeated dose intraperitoneal injections.
And they observed Myocarditis along with a host of other extremely toxic effects.
GNPs at all dosing regimens induced pathological changes after 27 days. Specifically, vacuolation, dilation of central vein and haemorrhage, vacuolation and dilation of central vein, damage of vacuolation, haemorrhage and degeneration of central vein, dilation of epithelial lining and hydropic degeneration oedema were observed in liver tissue. Kidney tissue of the treated groups showed acute vacuolization, dilation of epithelial lining, vacuolation and nucleus degeneration, nucleus damage, necrosis and epithelial degeneration. Heart tissue showed chemodectoma, toxic myocarditis, reddish brown atrophy; yellowish brown pigments suggesting lipofuscin granules as remnants of cell organelles and cytoplasmic material. The brain showed effects of secondary carcinoma, olegodendrocytoma small thin walled blood vessel and crytococcosis. Testicular tissue of treated groups showed spermatogenesis and vacuolation, dilation of germinal layer, degeneration of secondary spermatocytes, damage to the germinal layer and vacuolation. The lung showed damage of vacuolation, degeneration of central vein, inflammation, haemorrhage, d-shaped cells structure, hemosidophroages and lesion.
Continuing…
The control group heart showed normal histology of heart muscle tissues and single low dose treated group showed the chemodectoma, an ovoid mass, the tumours were enclosed in a fibrous capsule. The single high dose group indicated toxic myocarditis, and varying degree of damage, ranging from loss of striation to complete necrosis and fragmentation,
The Exeter study provides conclusive evidence that Graphene causes Myocarditis. On the other hand, McCullogh and Makis have never demostrated that Spike Proteins cause Myocarditis. They can only show that Myocarditis happens after vaccinations. The method by which “COVID” vaccines cause Myocarditis has never even been established, despite consensus that they do cause Myocarditis. I suspect that the reason the cause of Myocarditis resulting from “COVID” vaccines has never been properly determined is that it would expose that the vaccines contain Graphene.
Charles Wright
I have a friend who is a nurse had sz like activity 4-5 days after jab 2 in ‘21. Lots of pains and problems since. Last fall, had onset of chest pains intermittently, spent less than 24 hrs in ER. Few weeks ago chest pain with exercise. Few days ago, pericardial effusion on echo. Another young nurse I know, myocarditis in ‘21.
I asked several pediatricians from CHKD in ‘21 what the rate of myo was post ‘illness’ vs post shots. None would answer of course, bribed blind or cowards they are.
Well done